Over the past year, we have carefully considered whether — and how — life sciences companies can use AI tools in their clinical development ...

Cancer patients' messages about radiology/pathology reports: Insights for AI. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component ...

Ahead of Biomed Israel, Ittai Harel highlights a growing cohort of companies leveraging AI and data science tools to ...

An FDA initiative to implement real-time clinical trials could dramatically accelerate the pace at which new treatments ...

Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...

This systematic literature review and pooled rates analysis investigated the standard of care for patients with heart failure in the US post hospital discharge. Results: There were 31 studies that met ...

Final randomized Phase 2 Bria-IMT™ survival and quality of life data to be presentedBiomarker analyses from the ongoing Phase ...

Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...

PACB stock gains on Lucid Genomics deal, boosting HiFi data analysis and simplifying workflows to speed insights and expand ...

Brentwood, Tenn.-based HealthTrust Purchasing Group has acquired certain assets of Cardiac Data Solutions, an analytic platform that helps healthcare leaders improve clinical and financial outcomes, ...